Technical analysis of Incannex Healthcare Limited (IXHL): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA).
Price Performance
| 1 month | +5.81% |
| 3 months | +2.25% |
| Year-to-date | -66.11% |
| 1 year | -77.53% |
| 3 years | -97.59% |
52-Week Range
| 52-week High | $20.31 |
| 52-week Low | $2.49 |
| Avg Volume (90d) | 188K |
Technical Indicators
| SMA 50 | $3.28 |
| SMA 200 | $5.58 |
| Beta | 2.73 |
| 30-day Volatility (annualised) | 54.7% |
| Price vs SMA 50 | +11.0% |
| Price vs SMA 200 | -34.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $11.31 | |
| 2025-11 | $10.81 | -4.4% |
| 2025-12 | $10.74 | -0.6% |
| 2026-01 | $9.29 | -13.5% |
| 2026-02 | $4.24 | -54.4% |
| 2026-03 | $3.00 | -29.2% |
| 2026-04 | $4.39 | +46.3% |
| 2026-05 | $3.35 | -23.7% |
| 2026-06 | $3.76 | +12.2% |
| 2026-07 | $2.94 | -21.8% |
| 2026-08 | $3.35 | +13.9% |
| 2026-09 | $3.64 | +8.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-16 | $-1.99 | $12M |
| 2026-09-16 | | $5M |
| 2026-09-16 | | |
| 2026-09-16 | $-3.22 | $9M |
| 2026-09-16 | | |
| 2026-09-16 | | $5M |
Price
| Price | $3.64 |
| Market Cap | $44M |
| Exchange | NASDAQ |
| Country | AU |
Financial Health
| Piotroski F-Score | 3 |
| Altman Z-Score | -13.23 |